Literature DB >> 12873467

The surgical management of childhood orbito-temporal neurofibromatosis.

Vickie Lee1, Nicola K Ragge, J Richard O Collin.   

Abstract

PURPOSE: (1) To describe the natural history, changing manifestations and new signs of orbito-temporal neurofibromatosis (NF) during childhood and puberty. (2) To describe the surgical treatment and recommend guidelines for management of this condition in children compared to adults.Methods. Retrospective case note and serial photographic review.
RESULTS: There were 9 patients (5M, 4F) with orbito-temporal NF who were children (<16 years) at the time of first presentation with a minimum of 5 years follow up. All the patients had unilateral periorbital neurofibromatosis with blepharoptosis, orbital enlargement and hypoglobus. All nine patients underwent blepharoptosis surgery. Eight patients underwent neurofibroma debulking (and lid shortening) and lateral canthal reattachment. Three had enucleation of their blind eyes. Seven patients had two or more operations for their orbito-palpebral deformities. New signs included conjunctival and lacrimal gland infiltration with a secondary dry eye.
CONCLUSION: Blepharoptosis surgery is indicated if the visual axis is compromised and there is a chance of limiting amblyopia. Definitive surgery for appearance is best delayed until the age of 18 years, or when the disease progression has stabilised, unless there are compelling social reasons for earlier surgery.

Entities:  

Mesh:

Year:  2003        PMID: 12873467     DOI: 10.1016/s0007-1226(03)00172-3

Source DB:  PubMed          Journal:  Br J Plast Surg        ISSN: 0007-1226


  7 in total

Review 1.  Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Multidisciplinary Recommendations for Care.

Authors:  Robert A Avery; James A Katowitz; Michael J Fisher; Gena Heidary; Eva Dombi; Roger J Packer; Brigitte C Widemann
Journal:  Ophthalmology       Date:  2016-11-03       Impact factor: 12.079

2.  Orbitofacial neurofibromatosis: clinical characteristics and treatment outcome.

Authors:  I A Chaudhry; J Morales; F A Shamsi; W Al-Rashed; E Elzaridi; Y O Arat; C Jacquemin; D T Oystreck; T M Bosley
Journal:  Eye (Lond)       Date:  2011-12-23       Impact factor: 3.775

3.  Visual outcomes in children with neurofibromatosis type 1 and orbitotemporal plexiform neurofibromas.

Authors:  Robert A Avery; Eva Dombi; Kelly A Hutcheson; Maria T Acosta; Andrea M Baldwin; William P Madigan; Andrea Gillespie; Edmond J Fitzgibbon; Roger J Packer; Brigitte C Widemann
Journal:  Am J Ophthalmol       Date:  2013-02-26       Impact factor: 5.258

4.  Differential gene methylation and expression of HOX transcription factor family in orbitofacial neurofibroma.

Authors:  Antje Arnold; Eddie Luidy Imada; M Lisa Zhang; Deepak P Edward; Luigi Marchionni; Fausto J Rodriguez
Journal:  Acta Neuropathol Commun       Date:  2020-05-04       Impact factor: 7.801

5.  Initial Exploration on Temporal Branch of Facial Nerve Function Preservation in Plexiform Neurofibroma Resection.

Authors:  Xiaojie Hu; Melia Bogari; Andy Tan; Xiaoyan Gao; Yang Gao; Hui Chen; Wei Li; Yunbo Jin; Gang Ma; Xiaoxi Lin
Journal:  J Craniofac Surg       Date:  2016-09       Impact factor: 1.046

6.  Surgical correction in orbitotemporal neurofibromatosis with dystopia.

Authors:  Matthew Seung Suk Choi; Seung Hyup Choi; Jang Hyun Lee
Journal:  BMC Ophthalmol       Date:  2016-01-07       Impact factor: 2.209

7.  RNA-sequencing highlights differential regulated pathways involved in cell cycle and inflammation in orbitofacial neurofibromas.

Authors:  Eddie Luidy Imada; Diego Strianese; Deepak P Edward; Rawan alThaqib; Antionette Price; Antje Arnold; Hailah Al-Hussain; Luigi Marchionni; Fausto J Rodriguez
Journal:  Brain Pathol       Date:  2021-07-23       Impact factor: 6.508

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.